Novavax, Inc.Novavax, Inc.Novavax, Inc.

Novavax, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪1.35 B‬USD
2.61USD
‪−187.50 M‬USD
‪682.16 M‬USD
‪147.95 M‬
Beta (1Y)
1.17
Employees (FY)
952
Change (1Y)
−591 −38.30%
Revenue / Employee (1Y)
Net income / Employee (1Y)

About Novavax, Inc.


CEO
John C.s Jacobs
Headquarters
Gaithersburg
Founded
1987
ISIN
US6700024010
FIGI
BBG000NVSBL7
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Check out other big names from the same industry as NVAX.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on BOATS exchange Novavax, Inc. stocks are traded under the ticker NVAX.
We've gathered analysts' opinions on Novavax, Inc. future price: according to them, NVAX price has a max estimate of 25.00 USD and a min estimate of 6.00 USD. Watch NVAX chart and read a more detailed Novavax, Inc. stock forecast: see what analysts think of Novavax, Inc. and suggest that you do with its stocks.
NVAX reached its all-time high on Feb 8, 2022 with the price of 95.27 USD, and its all-time low was 3.73 USD and was reached on Feb 6, 2024. View more price dynamics on NVAX chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track Novavax, Inc. financials in yearly and quarterly reports right on TradingView.
Novavax, Inc. is going to release the next earnings report on Nov 5, 2025. Keep track of upcoming events with our Earnings Calendar.
NVAX earnings for the last quarter are 0.62 USD per share, whereas the estimation was 0.01 USD resulting in a ‪7.26 K‬% surprise. The estimated earnings for the next quarter are −0.49 USD per share. See more details about Novavax, Inc. earnings.
Novavax, Inc. revenue for the last quarter amounts to ‪239.24 M‬ USD, despite the estimated figure of ‪152.61 M‬ USD. In the next quarter, revenue is expected to reach ‪65.93 M‬ USD.
NVAX net income for the last quarter is ‪106.51 M‬ USD, while the quarter before that showed ‪518.65 M‬ USD of net income which accounts for −79.46% change. Track more Novavax, Inc. financial stats to get the full picture.
No, NVAX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 27, 2025, the company has 952 employees. See our rating of the largest employees — is Novavax, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Novavax, Inc. EBITDA is ‪407.48 M‬ USD, and current EBITDA margin is −26.90%. See more stats in Novavax, Inc. financial statements.
Like other stocks, NVAX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Novavax, Inc. stock right from TradingView charts — choose your broker and connect to your account.